Average Co-Inventor Count = 4.82
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (16 from 4,942 patents)
2. Roche Innovation Center Copenhagen A/s (1 from 46 patents)
3. F. Hoffmann-la Roche Ag (168 patents)
17 patents:
1. 11852627 - Oligonucleotides for inducing paternal UBE3A expression
2. 11320421 - Oligonucleotides for inducing paternal UBE3A expression
3. 10739332 - Oligonucleotides for inducing paternal UBE3A expression
4. 10718753 - Oligonucleotides for inducing paternal UBE3A expression
5. 10494633 - Oligonucleotides for inducing paternal UBE3A expression
6. 9714239 - N-phenyl-lactam derivatives capable of stimulating neurogenesis and their use in the treatment of neurological disorders
7. 9688675 - 1,7-naphthyridine derivatives
8. 9670206 - Pyrido[4,3-B]pyrazine-2-carboxamides as neurogenic agents for the treatment of neurodegenerative disorders
9. 9657014 - Substituted 1,6-naphthyridines
10. 9586903 - Isoquinoline derivatives
11. 9586966 - Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-one
12. 9464049 - Indole-carboxamides
13. 9440962 - Benzisoxazoles
14. 9365550 - Benzimidazoles as CNS active agents
15. 9315502 - Imidazopyridine derivatives